This unit of study expands on second and third year pharmaceutical science (Medicinal Chemistry, Pharmaceutics, Pharmacology, Biology and Biochemistry) by exposing students to drug development and developing biotechnologies, new drug targets and therapies as well as clinical trials. Students will be introduced to emerging biotechnologies and biological devices including drug delivery systems, new drug targets and therapies in order to be aware of ¿up and coming¿ biotechnologies and how they will impact on pharmaceutical care. Such knowledge will help students to decide their future career direction and give more understanding of practical problems encountered in design and use of biotechnology derived drugs. In addition, this unit of study promotes integration and application of prior knowledge in pharmaceutical science to solving problems in tasks encountered in research and development. This unit will help to understand pharmaceutical drug development as a possible career path and prepares students for professional accreditation. Students will develop knowledge related to biotechnology derived drugs and develop skills in obtaining and critically assessing peer-reviewed publications, as well as people skills from group work, conflict management and written and oral communication skills.
Up to 6 hours of lectures, eight 3 hour workshops and up to 60 hours of self-directed learning and group work.
Workshops (20%), written assignment (40%), and final exam (40%).
Foye W.O et. al. Principles of Medicinal Chemistry (5th Ed), Williams and Wilkins (2002) Shargel L and Yu ABC Applied Biopharmaceutics and Pharmacokinetics (1999) Burton, Evans.
PHAR3816 and PHAR3817 and PHAR3818 and PHAR3819 and PHAR3826 and PHAR3827 and PHAR3828 and PHAR3829Co-requisites
PHAR4821 and PHAR4822.